Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.

Details

Serval ID
serval:BIB_8BB8D7C83428
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study.
Journal
European journal of clinical pharmacology
Author(s)
Baettig D., Bondolfi G., Montaldi S., Amey M., Baumann P.
ISSN
0031-6970 (Print)
ISSN-L
0031-6970
Publication state
Published
Issued date
1993
Peer-reviewed
Oui
Volume
44
Number
4
Pages
403-405
Language
english
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Abstract
In a depressed patient, the addition of citalopram 40-60 mg per day to treatment with amitriptyline 75 mg per day had no effect on the plasma levels of amitriptyline and nortriptyline, but it led to clinical improvement without the appearance of adverse effects. This and similar findings in four other patients comedicated with citalopram and amitriptyline (2 patients), clomipramine or maprotiline suggest that citalopram differs from other selective serotonin reuptake inhibitors, such as fluvoxamine and fluoxetine, which have been shown to increase tricyclic antidepressant plasma levels.
Keywords
Antidepressive Agents, Tricyclic/blood, Antidepressive Agents, Tricyclic/therapeutic use, Citalopram/therapeutic use, Depressive Disorder/blood, Depressive Disorder/drug therapy, Drug Interactions, Drug Therapy, Combination, Female, Humans, Middle Aged
Pubmed
Web of science
Create date
12/01/2021 17:16
Last modification date
15/04/2023 6:51
Usage data